WINDTREE THERAPEUTICS INC /DE/ Net Cash Provided by (Used in) Investing Activities, Continuing Operations
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$24.00 thousand for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-21.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-21
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$4.00K.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$20.00K.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-09-30 was -$17.00K.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-06-30 was -$12.00K, a 105.85% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$188.00K.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$780.00K.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$608.00K.
- WINDTREE THERAPEUTICS INC /DE/ net cash provided by (used in) investing activities, continuing operations for fiscal 2012 was -$636.00K.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 1 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|---|
| 2017-06-30 | -$4.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-21 | -$24.00K 10-Q · filed 2017-08-21 | |||
| 2017-03-31 | -$20.00K 10-Q · filed 2017-05-15 | ||||
| 2016-12-31 | -$254.00K 10-K · filed 2017-03-31 | ||||
| 2016-09-30 | -$17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$29.00K derived: sum of 2 quarters · filed 2017-08-21 | -$166.00K 10-Q · filed 2016-11-14 | -$106.00K derived: sum of 4 quarters · filed 2017-08-21 | |
| 2016-06-30 | -$12.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-21 | -$149.00K 10-Q · filed 2017-08-21 | -$89.00K derived: sum of 3 quarters · filed 2017-08-21 | -$94.00K derived: sum of 4 quarters · filed 2017-08-21 | |
| 2016-03-31 | -$137.00K 10-Q · filed 2017-05-15 | -$77.00K derived: sum of 2 quarters · filed 2017-05-15 | -$82.00K derived: sum of 3 quarters · filed 2017-05-15 | $123.00K derived: sum of 4 quarters · filed 2017-05-15 | |
| 2015-12-31 | $60.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | $55.00K derived: sum of 2 quarters · filed 2017-03-31 | $260.00K derived: sum of 3 quarters · filed 2017-03-31 | -$188.00K 10-K · filed 2017-03-31 | |
| 2015-09-30 | -$5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $200.00K derived: sum of 2 quarters · filed 2016-11-14 | -$248.00K 10-Q · filed 2016-11-14 | -$349.00K derived: sum of 4 quarters · filed 2016-11-14 | |
| 2015-06-30 | $205.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-10 | -$243.00K 10-Q · filed 2016-08-10 | -$344.00K derived: sum of 3 quarters · filed 2016-08-10 | -$140.00K derived: sum of 4 quarters · filed 2016-08-10 | |
| 2015-03-31 | -$448.00K 10-Q · filed 2016-05-12 | -$549.00K derived: sum of 2 quarters · filed 2016-05-12 | -$345.00K derived: sum of 3 quarters · filed 2016-05-12 | -$731.00K derived: sum of 4 quarters · filed 2016-05-12 | |
| 2014-12-31 | -$101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-29 | $103.00K derived: sum of 2 quarters · filed 2016-03-29 | -$283.00K derived: sum of 3 quarters · filed 2016-03-29 | -$780.00K 10-K · filed 2016-03-29 | |
| 2014-09-30 | $204.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$182.00K derived: sum of 2 quarters · filed 2015-11-05 | -$679.00K 10-Q · filed 2015-11-05 | ||
| 2014-06-30 | -$386.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$883.00K 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | -$497.00K 10-Q · filed 2015-05-11 | ||||
| 2013-12-31 | -$608.00K 10-K · filed 2015-03-16 | ||||
| 2012-12-31 | -$636.00K 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |